TY - JOUR
T1 - International cooperation to improve access to and sustain effectiveness of antimicrobials
AU - Årdal, Christine
AU - Outterson, Kevin
AU - Hoffman, Steven J.
AU - Ghafur, Abdul
AU - Sharland, Mike
AU - Ranganathan, Nisha
AU - Smith, Richard
AU - Zorzet, Anna
AU - Cohn, Jennifer
AU - Pittet, Didier
AU - Daulaire, Nils
AU - Morel, Chantal
AU - Rizvi, Zain
AU - Balasegaram, Manica
AU - Dar, Osman A.
AU - Heymann, David L.
AU - Holmes, Alison H.
AU - Moore, Luke S.P.
AU - Laxminarayan, Ramanan
AU - Mendelson, Marc
AU - Røttingen, John Arne
N1 - Publisher Copyright:
© 2016 Elsevier Ltd.
PY - 2016/1/16
Y1 - 2016/1/16
N2 - Securing access to effective antimicrobials is one of the greatest challenges today. Until now, efforts to address this issue have been isolated and uncoordinated, with little focus on sustainable and international solutions. Global collective action is necessary to improve access to life-saving antimicrobials, conserving them, and ensuring continued innovation. Access, conservation, and innovation are beneficial when achieved independently, but much more effective and sustainable if implemented in concert within and across countries. WHO alone will not be able to drive these actions. It will require a multisector response (including the health, agriculture, and veterinary sectors), global coordination, and financing mechanisms with sufficient mandates, authority, resources, and power. Fortunately, securing access to effective antimicrobials has finally gained a place on the global political agenda, and we call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action.
AB - Securing access to effective antimicrobials is one of the greatest challenges today. Until now, efforts to address this issue have been isolated and uncoordinated, with little focus on sustainable and international solutions. Global collective action is necessary to improve access to life-saving antimicrobials, conserving them, and ensuring continued innovation. Access, conservation, and innovation are beneficial when achieved independently, but much more effective and sustainable if implemented in concert within and across countries. WHO alone will not be able to drive these actions. It will require a multisector response (including the health, agriculture, and veterinary sectors), global coordination, and financing mechanisms with sufficient mandates, authority, resources, and power. Fortunately, securing access to effective antimicrobials has finally gained a place on the global political agenda, and we call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action.
UR - http://www.scopus.com/inward/record.url?scp=84954389558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84954389558&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(15)00470-5
DO - 10.1016/S0140-6736(15)00470-5
M3 - Review article
C2 - 26603920
AN - SCOPUS:84954389558
SN - 0140-6736
VL - 387
SP - 296
EP - 307
JO - The Lancet
JF - The Lancet
IS - 10015
ER -